RU2325910C2 - Новые сложные эфиры этоногестрела - Google Patents

Новые сложные эфиры этоногестрела Download PDF

Info

Publication number
RU2325910C2
RU2325910C2 RU2004138807/15A RU2004138807A RU2325910C2 RU 2325910 C2 RU2325910 C2 RU 2325910C2 RU 2004138807/15 A RU2004138807/15 A RU 2004138807/15A RU 2004138807 A RU2004138807 A RU 2004138807A RU 2325910 C2 RU2325910 C2 RU 2325910C2
Authority
RU
Russia
Prior art keywords
etonogestrel
esters
ethonogestrel
male
female
Prior art date
Application number
RU2004138807/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2004138807A (ru
Inventor
НЕЙС Хенрик ДЕ (NL)
НЕЙС Хенрик ДЕ
Дер Ворт Хендрикус Адрианус Антониус Ван (NL)
ДЕР ВОРТ Хендрикус Адрианус Антониус ВАН
Дирк ЛЕЙСЕН (NL)
Дирк Лейсен
Арей Ян ГРОТЕНХЕЙС (NL)
Арей Ян ГРОТЕНХЕЙС
Original Assignee
Н.В.Органон
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Н.В.Органон filed Critical Н.В.Органон
Publication of RU2004138807A publication Critical patent/RU2004138807A/ru
Application granted granted Critical
Publication of RU2325910C2 publication Critical patent/RU2325910C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2004138807/15A 2002-05-30 2003-05-22 Новые сложные эфиры этоногестрела RU2325910C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077119.2 2002-05-30
EP02077119 2002-05-30

Publications (2)

Publication Number Publication Date
RU2004138807A RU2004138807A (ru) 2005-05-27
RU2325910C2 true RU2325910C2 (ru) 2008-06-10

Family

ID=29595014

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004138807/15A RU2325910C2 (ru) 2002-05-30 2003-05-22 Новые сложные эфиры этоногестрела

Country Status (30)

Country Link
US (1) US7323454B2 (enExample)
EP (1) EP1513861B1 (enExample)
JP (1) JP4716726B2 (enExample)
KR (1) KR20050009723A (enExample)
CN (2) CN101100480A (enExample)
AR (1) AR040130A1 (enExample)
AT (1) ATE349458T1 (enExample)
AU (1) AU2003238081B2 (enExample)
BR (1) BR0311254A (enExample)
CA (1) CA2487722C (enExample)
CO (1) CO5631449A2 (enExample)
DE (1) DE60310714T2 (enExample)
DK (1) DK1513861T3 (enExample)
ES (1) ES2277085T3 (enExample)
HR (1) HRP20041101A2 (enExample)
IL (1) IL165087A0 (enExample)
IS (1) IS2421B (enExample)
MX (1) MXPA04011797A (enExample)
NO (1) NO20044898L (enExample)
NZ (1) NZ536619A (enExample)
PE (1) PE20040068A1 (enExample)
PL (1) PL373855A1 (enExample)
PT (1) PT1513861E (enExample)
RS (1) RS97604A (enExample)
RU (1) RU2325910C2 (enExample)
SI (1) SI1513861T1 (enExample)
TW (1) TW200403065A (enExample)
UA (1) UA80126C2 (enExample)
WO (1) WO2003102012A2 (enExample)
ZA (1) ZA200410410B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
JP5756588B2 (ja) 2005-07-15 2015-07-29 ミセル テクノロジーズ、インコーポレイテッド 制御されたモルホロジーの薬剤粉末を含むポリマーコーティング
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
CA2996768C (en) 2006-04-26 2020-12-08 Micell Technologies, Inc. Coatings containing multiple drugs
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
JP5603598B2 (ja) 2007-01-08 2014-10-08 ミセル テクノロジーズ、インコーポレイテッド 生物分解層を有するステント
US9433516B2 (en) 2007-04-17 2016-09-06 Micell Technologies, Inc. Stents having controlled elution
BRPI0910969B8 (pt) 2008-04-17 2021-06-22 Micell Technologies Inc dispositivo
WO2011009096A1 (en) 2009-07-16 2011-01-20 Micell Technologies, Inc. Drug delivery medical device
EP2313122B1 (en) 2008-07-17 2019-03-06 Micell Technologies, Inc. Drug delivery medical device
EP2411083A4 (en) 2009-03-23 2013-11-13 Micell Technologies Inc MEDICAL ACTIVE COMPOSITION DEVICE
EP2413847A4 (en) 2009-04-01 2013-11-27 Micell Technologies Inc COATED STENTS
EP2531140B1 (en) 2010-02-02 2017-11-01 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
WO2011133655A1 (en) 2010-04-22 2011-10-27 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
EP2593039B1 (en) 2010-07-16 2022-11-30 Micell Technologies, Inc. Drug delivery medical device
WO2013012689A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
JP6330024B2 (ja) 2013-03-12 2018-05-23 マイセル・テクノロジーズ，インコーポレイテッド 生体吸収性バイオメディカルインプラント
JP2016519965A (ja) 2013-05-15 2016-07-11 マイセル・テクノロジーズ，インコーポレイテッド 生体吸収性バイオメディカルインプラント
RU2595818C1 (ru) * 2015-05-25 2016-08-27 Федеральное государственное бюджетное научное учреждение "Научный центр проблем здоровья семьи и репродукции человека" Способ комплексного лечения дисфункции яичников при применении гормонального контрацептива имплантата "импланона"
CN111057120B (zh) * 2019-12-27 2021-04-27 苏州翔实医药发展有限公司 一种依托孕烯衍生物a及其制备方法和用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19613698A1 (de) * 1995-07-17 1997-01-23 Schering Ag Mittel zur transdermalen Applikation enthaltend Ester des 13-Ethyl-17ß-hydroxy-11-methylen-18,19-dinor-17alpha-pregn-4-en-20-yn-3-ons
WO1997006807A2 (de) * 1995-08-17 1997-02-27 Schering Aktiengesellschaft Kombinationspräparat zur kontrazeption, kits diese enthaltend und eine methode diese verwendend
RU2113849C1 (ru) * 1995-10-28 1998-06-27 Йенафарм ГмбХ & Ко., КГ Комбинированный препарат для контрацепции на базе природных эстрогенов

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1013284B (de) 1956-03-22 1957-08-08 Schering Ag Verfahren zur Einfuehrung der Reste wenig reaktionsfaehiger Carbonsaeuren, insbesondere des ª‰-Cyclopentyl-propionylrestes, in die 17ª‡-staendige Oxygruppe solcher Steroide, die am Kohlenstoffatom 17 neben der Oxygruppe eine Acetylgruppe tragen
GB845442A (en) 1956-03-22 1960-08-24 Schering Ag Manufacture of steroid compounds
GB8313921D0 (en) * 1983-05-19 1983-06-22 World Health Org Contraceptive compositions
DE4227989A1 (de) 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
DE4240806A1 (de) 1992-12-01 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 14alpha,17alpha-Ethanoestra-1,3,5(10)-trien-3,17beta-diol
JPH07101884A (ja) 1993-10-01 1995-04-18 Sanei Gen F F I Inc 水溶性ヘミセルロースを含有する製剤
FI962618A7 (fi) * 1993-12-27 1996-06-25 Akzo Nobel Nv Perkutaanisesti absorboituva valmiste
WO1997003709A1 (de) 1995-07-17 1997-02-06 Schering Aktiengesellschaft Mittel zur transdermalen applikation enthaltend ester des 3-ketodegestrel
WO1999067270A1 (en) 1998-06-19 1999-12-29 Akzo Nobel N.V. Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)
AU756739B2 (en) 1998-06-19 2003-01-23 N.V. Organon Testosterone derivative
US6180682B1 (en) 1999-01-26 2001-01-30 Virgil A. Place Buccal drug delivery system for use in male contraception
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19613698A1 (de) * 1995-07-17 1997-01-23 Schering Ag Mittel zur transdermalen Applikation enthaltend Ester des 13-Ethyl-17ß-hydroxy-11-methylen-18,19-dinor-17alpha-pregn-4-en-20-yn-3-ons
WO1997006807A2 (de) * 1995-08-17 1997-02-27 Schering Aktiengesellschaft Kombinationspräparat zur kontrazeption, kits diese enthaltend und eine methode diese verwendend
RU2113849C1 (ru) * 1995-10-28 1998-06-27 Йенафарм ГмбХ & Ко., КГ Комбинированный препарат для контрацепции на базе природных эстрогенов

Also Published As

Publication number Publication date
RS97604A (sr) 2006-10-27
IS2421B (is) 2008-10-15
WO2003102012A2 (en) 2003-12-11
NO20044898L (no) 2005-02-25
IL165087A0 (en) 2005-12-18
PL373855A1 (en) 2005-09-19
MXPA04011797A (es) 2005-03-31
NZ536619A (en) 2007-09-28
KR20050009723A (ko) 2005-01-25
ZA200410410B (en) 2006-02-22
DK1513861T3 (da) 2007-04-10
CA2487722A1 (en) 2003-12-11
ATE349458T1 (de) 2007-01-15
UA80126C2 (en) 2007-08-27
RU2004138807A (ru) 2005-05-27
AR040130A1 (es) 2005-03-16
ES2277085T3 (es) 2007-07-01
TW200403065A (en) 2004-03-01
HK1072609A1 (en) 2005-09-02
CN101100480A (zh) 2008-01-09
US7323454B2 (en) 2008-01-29
US20050222113A1 (en) 2005-10-06
JP4716726B2 (ja) 2011-07-06
BR0311254A (pt) 2005-03-15
PT1513861E (pt) 2007-03-30
EP1513861B1 (en) 2006-12-27
CO5631449A2 (es) 2006-04-28
EP1513861A2 (en) 2005-03-16
AU2003238081B2 (en) 2008-09-18
AU2003238081A1 (en) 2003-12-19
SI1513861T1 (sl) 2007-06-30
DE60310714D1 (de) 2007-02-08
WO2003102012A9 (en) 2005-01-13
HRP20041101A2 (en) 2004-12-31
CN1314701C (zh) 2007-05-09
JP2005532350A (ja) 2005-10-27
WO2003102012A3 (en) 2004-04-22
PE20040068A1 (es) 2004-02-18
CA2487722C (en) 2011-07-19
DE60310714T2 (de) 2007-10-11
CN1692122A (zh) 2005-11-02
IS7528A (is) 2004-11-15

Similar Documents

Publication Publication Date Title
RU2325910C2 (ru) Новые сложные эфиры этоногестрела
JP2009167188A (ja) 新規１９−ノル−プレグネン誘導体類
JP2002518514A (ja) テストステロン誘導体
RU2322986C2 (ru) Применение новых сложных эфиров этоногестрела
RU2328289C2 (ru) Контрацептивная инъекция масляного раствора, вводимая самостоятельно
HK1072609B (en) New etonogestrel esters
HK1072568B (en) Use of new etonogestrel esters

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20090523